SARA EBEL: Open Payments
NPI 1750693289 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,353 in 164 payments from 22 companies in 2025. Trend: 2023 $2,238 · 2024 $8,880 · 2025 $5,353
Food & beverage: $3,898Consulting: $1,260Travel & lodging: $138Education: $57
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $1,929 |
| AstraZeneca Pharmaceuticals LP | 26 | $676 |
| GlaxoSmithKline, LLC. | 19 | $389 |
| Viatris Specialty LLC | 12 | $340 |
| Regeneron Healthcare Solutions, Inc. | 13 | $231 |
| Grifols USA, LLC | 5 | $217 |
| Merck Sharp & Dohme LLC | 8 | $198 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $192 |
| Insmed, Inc. | 10 | $178 |
| Verona Pharma, Inc. | 9 | $141 |
Products named: DUPIXENT, TEZSPIRE, YUPELRI, NUCALA, FASENRA, Prolastin-C Liquid, Arikayce, Ohtuvayre.
Industry payments across NC — which companies pay providers there.
